Tiziana Life Sciences (TLSA) Assets (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Assets of $11.5 million for Q4 2025, up 1.87% year-over-year from $11.3 million in Q4 2024, and down 30.74% quarter-over-quarter from $16.6 million in Q2 2025.
Tiziana Life Sciences (TLSA) Assets (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Assets history runs 9 years deep, the most recent figure standing at $11.5 million for Q4 2025.
- In Q4 2025, Assets rose 1.87% year-over-year to $11.5 million; the TTM figure through Dec 2025 stood at $11.5 million (up 1.87% YoY), while the FY2025 annual figure was $11.5 million, up 1.87% from the prior year.
- Assets for Q4 2025 stood at $11.5 million, down from $16.6 million in the prior quarter.
- The five-year high for Assets was $57.9 million in Q2 2021, with the low at $11.0 million in Q2 2024.
- The 5-year median for Assets is $17.0 million (2023), against an average of $24.8 million.
- The sharpest annual moves came in 2021 and 2023: Assets surged 344.18% in 2021, then slumped 53.98% in 2023.
- Tiziana Life Sciences' Assets stood at $48.8 million in 2021, then tumbled by 45.77% to $26.5 million in 2022, then plunged by 53.98% to $12.2 million in 2023, then decreased by 7.39% to $11.3 million in 2024, then rose by 1.87% to $11.5 million in 2025.
- Business Quant data shows TLSA's Assets at $11.5 million in Q4 2025, $16.6 million in Q2 2025, and $11.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | 11.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.50 Mn |
| Jun 30, 2025 | 16.60 Mn |
| Dec 31, 2024 | 11.28 Mn |
| Jun 30, 2024 | 10.96 Mn |
| Dec 31, 2023 | 12.18 Mn |
| Jun 30, 2023 | 17.42 Mn |
| Dec 31, 2022 | 26.48 Mn |
| Jun 30, 2022 | 35.13 Mn |
| Dec 31, 2021 | 48.83 Mn |
| Jun 30, 2021 | 57.87 Mn |
| Dec 31, 2020 | 68.35 Mn |
| Jun 30, 2020 | 13.03 Mn |
| Dec 31, 2019 | 2.32 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Dec 31, 2018 | 6.99 Mn |
| Jun 30, 2018 | 1.79 Mn |
| Dec 31, 2017 | 2.43 Mn |